Labshake search
Citations for Bio X Cell :
1 - 50 of 616 citations for 6 Pteridinepropanoic acid 2 4 diamino α 4 carboxyphenyl α 2 propyn 1 yl since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Cancer Biology 2022Quote: ... α-PD-1 (BioXCell Clone RMP1-14 and catalog number BE0146) ...
-
bioRxiv - Immunology 2021Quote: ... α-ICAM-1 (YN1/1.7.4) (BioXCell), α- VCAM-1 (Phe25-Glu698 ...
-
bioRxiv - Immunology 2022Quote: ... mice received 2 injections (37.5 µg/g) of either α-CSF1R (Clone AFS98, Bio X Cell) or IgG2a isotype control (Clone 2A3 ...
-
bioRxiv - Immunology 2021Quote: ... plus 2 µg/mL anti-IL-4 antibody (BioXcell, Clone: 11B11); Th17 ...
-
bioRxiv - Cancer Biology 2020Quote: ... α-PD-1 antibody (200 μg; RMP1-14, BioXcell) was used ...
-
bioRxiv - Immunology 2021Quote: ... 1% GlutaMAX™ and 1% N-2-hydroxyethylpiperazine-N-2-ethane sulfonic acid [Gibco® HEPES]) and used as follow: TH1 conditions with anti–IL-4 (10 μg/mL, BioXCell, #BE0045) and IL-12 (10 ng/mL ...
-
bioRxiv - Microbiology 2021Quote: ... 10 μg·ml-1 anti-IL-4 and 10 μg·ml-1 anti-IL-2 (Bio X Cell, Cat# BE0043-1, RRID:AB_1107705). For Treg cell differentiation ...
-
bioRxiv - Cancer Biology 2024Quote: Antibody administration of anti-VLA-4 (clone PS/2, Bio X Cell #BE0071), anti-4-1BB (clone LOB12.3 ...
-
bioRxiv - Immunology 2021Quote: ... K18-hACE2 mice were injected intraperitoneally with 2 mg per mouse of α-IFNAR1 blocking antibody (BioXcell, #BE0241, clone MAR1-5A3) 1 day before infection.
-
bioRxiv - Cancer Biology 2020Quote: ... anti-IL-6 or anti-CTLA-4 antibodies (BioXCell). For CXCR3 blockade studies ...
-
bioRxiv - Immunology 2021Quote: ... 2 µg/mL anti-IL-4 and anti-IFNγ antibody (BioXcell, Clone: XMG 1.2). 10 µM SB525334 was used to replace TGF-β to inhibit TGF-β signaling if required ...
-
bioRxiv - Immunology 2019Quote: ... blocked with α-CD16/32 (clone 2.4G2, BioXCell) for 5-10 minutes at 4°C ...
-
bioRxiv - Immunology 2021Quote: ... injected with 100 μg α-CD62L (MEL14) (BioXCell), and control mice with PBS alone ...
-
bioRxiv - Cancer Biology 2022Quote: ... or α-CD8 antibody (200 μg; 2.43, BioXcell) twice per week ...
-
bioRxiv - Immunology 2020Quote: ... 500 μg α-IL-17A (clone 17F3, BioXcell) was administered ip at days -1 ...
-
bioRxiv - Immunology 2019Quote: ... and α-CD28 (200 ng/mL; 9.3; BioXCell) on goat-α-mouse (10 µg/mL ...
-
bioRxiv - Immunology 2020Quote: ... 500 µg of α-IL21R (Clone: 4A9, BioXCell) was injected through I.P weekly starting at 14 d.p.i ...
-
bioRxiv - Cancer Biology 2022Quote: ... mice were injected intraperitoneally with an α-Gr-1 (200 μg; RB6-8C5, BioXcell) twice per week ...
-
bioRxiv - Cancer Biology 2023Quote: ... or isotype control antibody (200μg twice weekly for 2 weeks, a total of 4 times; clone LTF2, BioXcell).
-
bioRxiv - Cancer Biology 2023Quote: ... injection of either a-PD-L1 antibody (200μg twice weekly for 2 weeks, a total of 4 times; clone 10F.9G2, BioXcell) or isotype control antibody (200μg twice weekly for 2 weeks ...
-
bioRxiv - Immunology 2020Quote: ... T cells were activated by α-CD28 (5 ug/ml; BioXCell) and plate-bound α-CD3 (clone 145-TC11 ...
-
bioRxiv - Microbiology 2020Quote: ... The mouse α-NP monoclonal antibody H16-L10-4R5 (Bioxcell BE0159) (Yewdell et al. ...
-
bioRxiv - Immunology 2022Quote: ... The Fc receptor was blocked with α-mouse CD16/CD32 (BioXcell). Cells were then incubated in solutions with antibodies targeting surface makers on ice for 30min ...
-
bioRxiv - Immunology 2022Quote: ... 100µg and 100µg of α-PD1 (RMP1-14; Bio X Cell) on day 7 ...
-
bioRxiv - Cancer Biology 2022Quote: ... mice were administered with up to four doses of 300 µg of α-PD-1 antibody (BioXCell) or rat isotype control antibody IgG2a (BioXCell ...
-
bioRxiv - Immunology 2020Quote: ... and plate-bound α-CD3 (clone 145-TC11, 5 ug/ml; BioXCell) in complete RPMI medium supplemented with 10% fetal bovine serum ...
-
bioRxiv - Immunology 2020Quote: ... mice were injected with 250 µg α-CD4 weekly (Clone: GK1.5, BioXCell) starting at 14 d.p.i ...
-
bioRxiv - Microbiology 2023Quote: ... injection with 150 µg of α-m Ly-6G (clone: 1A8, BioXCell) prior to infection with S ...
-
bioRxiv - Cancer Biology 2022Quote: ... mice were injected IP with either an α-CD4 (200 μg; GK1.5, BioXcell) or α-CD8 antibody (200 μg ...
-
bioRxiv - Immunology 2022Quote: ... in the presence of 10μg/ml rIL-6 (R&D) and neutralizing antibodies to IL-2 (JES6-1A12 BioXcell, 5μg/ml and S4B6-1 BioXcell, 5μg/mL).
-
bioRxiv - Immunology 2020Quote: ... CD40L blockade or iBALT depletion were achieved by the injection of 250 µg of α-CD40L (Clone: MR-1, BioXCell) or 250 µg of LTβR-Ig weekly respectively ...
-
bioRxiv - Cancer Biology 2022Quote: ... mice were injected intraperitoneally (IP) with an α-NK1.1 antibody (250 μg; PK136, BioXcell) twice per week ...
-
bioRxiv - Bioengineering 2023Quote: ... Mice in groups receiving αPD-1 and αCTLA-4 (100 µg, every 3 days for 4 injections, BioXcell, West Lebanon NH) were treated intraperitoneally ...
-
bioRxiv - Immunology 2023Quote: ... 100 µg of CD4 and 100 µg of CD8 depleting antibodies were injected intraperitoneally in 100 µL sterile PBS per mouse 24 hours before challenge infection. 100 µg (Fig. 1) or 200 µg of the isotype control (Fig. 6) (clone LTF-2, Bio X Cell) were injected intraperitoneally in 100 µL of sterile PBS per mouse at the same time in control groups.
-
bioRxiv - Immunology 2020Quote: ... Inhibition of PD-1/PD-L1 signaling was performed by intraperitoneal injection of 1mg of α-PD-L1 (clone: 10F.9G2, BioXcell), while control mice were treated with the IgG2b isotype (clone ...
-
bioRxiv - Immunology 2019Quote: ... αIL-4 (5 μg mL−1, clone 11B11; Bio X Cell), rhTGF-β1 (2 ng mL−1 ...
-
bioRxiv - Immunology 2021Quote: ... and anti-IL-4 (BioXCell); for Th2 ...
-
bioRxiv - Immunology 2023Quote: ... with anti-IL-2 (S4B6-1, BioXcell, 100 µg), anti-CD154 (MR1 ...
-
bioRxiv - Immunology 2021Quote: ... mice were treated with 200 μg anti-mouse TNF-α (XT3.11 clone, BioXcell, West Lebanon, NH) or rat IgG1 isotype antibody intraperitoneally 1 h before infection ...
-
bioRxiv - Immunology 2019Quote: Mice were IP injected with 450 µg monoclonal anti-mouse TNF-α antibody (XT3.11, BE00058, BioXCell) or 450 µg monoclonal rat IgG1 isotype control (Clone TNP6A7 ...
-
bioRxiv - Immunology 2022Quote: ... or were completely clear of tumors: anti-CD8-α for CD8+ T cells (clone 2.43, BioXCell), anti-CD4 for CD4+ T cells (clone GK1.5 ...
-
bioRxiv - Immunology 2023Quote: ... or were completely clear of tumors: anti-CD8-α for CD8+ T cells (clone 2.43, BioXCell), anti-CD4 for CD4+ T cells (clone GK1.5 ...
-
bioRxiv - Immunology 2023Quote: ... and anti-CD28 (2 µg/ml, clone PV-1; BioXCell) or anti-NKG2D (10 µg/ml ...
-
bioRxiv - Immunology 2023Quote: ... They were differentiated (9) for 2 days with plate bound anti-CD3 and anti-CD28 (2 μg mL-1 each; BioXcell) into Th1 cells – 10 ng mL-1 rmIL-12 (R&D Biosystems ...
-
bioRxiv - Immunology 2020Quote: ... LFA blocking antibody (M17/4; BioXCell) was administered i.p ...
-
bioRxiv - Cancer Biology 2020Quote: ... and anti-CTLA-4 (BioXCell, BE0164) or isotype control (MSD IgG1 control for muDX400 ...
-
bioRxiv - Cancer Biology 2023Quote: ... and anti-CTLA-4 (BioXCell # BE0164) were diluted in PBS and dosed at 10 mg/kg every 3 days ...
-
bioRxiv - Cancer Biology 2021Quote: ... 250 μg PD-1 and CTLA-4 blocking (clone 9H10, BioXCell, Lebanon, NH) antibodies were injected intraperitoneally thrice per week for four weeks or a combination of PD-1 CTLA-4 antibodies with iBET762 were used.
-
bioRxiv - Immunology 2019Quote: ... Cells were initially activated for 72 hours on plate-bound α-CD3 (200 ng/mL; OKT3; BioXCell) and α-CD28 (200 ng/mL ...
-
bioRxiv - Immunology 2023Quote: ... CD8+ T cells were depleted by intraperitoneal administration of 100 µg of α-CD8 depleting antibody (BioXcell) on P6 ...